Beiersdorf and Terumo to set up joint venture:
This article was originally published in Clinica
The German company, Beiersdorf, is to start a cooperation agreement with the Japanese company, Terumo, from April 1 1998. The two companies plan to form a 50:50 joint venture later this year. Under the agreement, the joint venture will import and market Beiersdorf's wound care and phlebology products for hospital use. Tokyo-based Terumo will handle sales in Japan. Beiersdorf's Japanese subsidiary, which formerly marketed the products, will now concentrate on selling the company's industrial products.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.